Lux Selvanesan

Commercial cancer research scientist. Molecular diagnostics, molecular technology, MDx. Multi-Ethnic, Inter-faith respect..."b the change u want to see"

[Lux Selvanesan @Laxi9]

congratulations @Weranja @USANZUrology @Cxbladder #bladdercancer #biomarker #haematuria

[USANZ @USANZUrology]

The Best Oncology Presentation Award was presented at #USANZ26. The recipient is invited to deliver the USANZ Lecture at the @ANZUPtrials ASM. This year's recipient is @Weranja for his work on Cxbladder triage and urothelial carcinoma detection in patients with haematuria.

[Cxbladder @Cxbladder]

News to share! Expert Panel Expresses Clear Support for Urine-Based Biomarkers in Hematuria Evaluation. Learn more: https://t.co/jL1mCPjSpD

[Pacific Edge @PacificEdgeLtd]

Featured article! Leading industry platform @UrologyTimes reviews the DRIVE study, now published in Urologic Oncology. DRIVE provides clinical validation for our next generation Cxbladder test Triage Plus. Cxbladder Triage Plus employs a novel combination of mRNA and RNA biomarkers to extend best in class performance, enhancing the risk stratification of patients presenting with hematuria. Review the article: https://t.co/tXKNy2Aoav

[UroToday.com @urotoday]

Platform reduces unnecessary cystoscopies for hematuria patients. @DrJohnSfakianos discusses how @Cxbladder is changing the game in microhematuria & #BladderCancer surveillance. With 99–100% NPV, Triage & Monitor tests help avoid unnecessary cystoscopies & personalize follow-up—now backed by #STRATA trial data & @AmerUrological guideline updates. #WatchNow > https://t.co/iHGULh5YH4 @zklaassen_md

[Cxbladder @Cxbladder]

Improving Diagnosis and Treatment of Microhematuria: Kaiser Permanente's Dr. Ronald Loo and Dr. Christopher Filson join Dr. Zachary Klaassen to discuss the real-world implementation of Cxbladder Triage within the Kaiser Health System for risk stratification, including the results of a published study of over 3,300 patients. Watch the video: https://t.co/dhqlNOE3Em (via @urotoday)

[Pacific Edge @PacificEdgeLtd]

Host Diane Newman and Pacific Edge Senior Medical Director Dr. Jay Jhaveri discuss key changes incorporated into the 2025 AUA/SUFU Microhematuria Guideline and the implications for clinical practice. The updated Guideline emphasizes refined risk stratification and suggests a more efficient approach to managing intermediate risk patients leveraging Cxbladder Triage. #WatchNow https://t.co/DluYHZQezU (via @GRUrology)

[DigitalMore.co 📱ดิจิตอลมอร์ @DigitalMoreco]

Codex Genetics Expands Precision Oncology Portfolio with Cxbladder Genomic Urine Tests
https://t.co/Ejl7wa3OtS

[Lux Selvanesan @Laxi9]

I am taking part in relay for Life - Do something remarkable and get involved today! https://t.co/1t8Y6exuYO #RelayForLifeNZ via @NZCancerSo

[Pacific Edge @PacificEdgeLtd]

Celebrating success in style. Late last year we decided to mark the development of a new RNA/DNA sample stabilisation buffer - a significant operational and logistical milestone - with a brew of a different sort. Learn more: https://t.co/SxFqfu0msg

[Lux Selvanesan @Laxi9]

🎓𝐓𝐰𝐨 𝐠𝐫𝐞𝐚𝐭 𝟐𝟎𝟐𝟒-𝟐𝟓 𝐬𝐮𝐦𝐦𝐞𝐫 𝐢𝐧𝐭𝐞𝐫𝐧𝐡𝐢𝐩𝐬 𝐜𝐥𝐨𝐬𝐞 𝐓𝐎𝐃𝐀𝐘! 𝐚𝐭 @PacificEdgeLtd @Cxbladder
🚨 Email CV & cover letter to [email protected]. Vit our Careers Hub at https://t.co/d9pkKfWOL0 to learn about the experience from previous interns.

[Lux Selvanesan @Laxi9]

@jlinscott_uro discusses future directions for utDNA research in #BladderCancer. But why utDNA and not total urine DNA? Explore the potential benefits and implications of this focused approach in cancer detection and treatment. @MoffittNews
https://t.co/wuJ7BuYUoJ via @onclive

[Lux Selvanesan @Laxi9]

Advancements in #BladderCancer treatment! updates, including immunotherapy & targeted therapy options
Innovationshttps://www.onclive.com/view/park-and-grivas-expand-on-treatment-updates-in-bladder-cancer via @onclive#CancerResearch #Oncology #MedicalNews #Healthcare

[Ashish M. Kamat, MD, MBBS @UroDocAsh]

The IBCG Quick Guide to Non-Muscle Invasive Bladder Cancer (NMIBC)

Bladder Cancer Quick Reference Sheet summarizes essential details on diagnosis, treatment options, and follow-up for NMIBC all in one convenient place #AUA24 #EAU24 #IBCG24 #ASCO24

Designed by @AmandaMyersMD #OncSurgery @MDAndersonNews

@PGrivasMDPhD @shilpaonc @UrogerliMD @SimaPorten @pjhensley11 @SWilliams_MD

[Pacific Edge @PacificEdgeLtd]

From Science to Clinical Utility: Cxbladder Monitor - #BladderCancer Surveillance for Patients with Urothelial Carcinoma. Dr Neal Shore, Dr Joshua Meeks, and Dr Tamer Aboushwareb, Chief Medical Officer, Pacific Edge: https://t.co/poo4QZ1vJr (via @urotoday)

[Lux Selvanesan @Laxi9]

#SOLANA $SOL the best blockchain ever! https://t.co/rNIG5tbgD4

[Lux Selvanesan @Laxi9]

wooow! @AtsushiI0308 @hiroto_eguchi @atom01210 @miragefan2012 @mg7sZLCUqh46RND @sky_069 @yuu_oo30 @bibisanjapan @fm_fm_9 @Taku03Kc100 @TK_1183 @0829as1 @hasamihasmu @wangruihana

[Lux Selvanesan @Laxi9]

Bull Run will be like none other $SOL #solana https://t.co/irAfeOUfMq

[Lux Selvanesan @Laxi9]

hugeannounce @spx93hw9 @once_dead_man @keikanya @M7eSXjNM9VVPmOY @gAzRU5kJer5d639 @2iy9j1ChgADuI2P @TW_GUM @fukuasafuku @cpadk15 @hiro_i_1204 @waterdragon6848 @baccaratyaritai @yopilog09 @t13410

[Lux Selvanesan @Laxi9]

LFG! $SOL 100$ this year! #bonk $BONK https://t.co/QeMd78xUiU

[Lux Selvanesan @Laxi9]

hugeannounce @chichiowski @yokojun11 @boukokukabu @prius725913 @CooooooooolOh @hiraishimba @ukyyyyykusa @3to3to4 @kaoru_kingmanbo @LOx4T6FevbjByTV @nem74864112 @ohcNiSIbevKgpuf @FASUU2 @seika1100